ConductScience.org, home
TACSTD2: tumor associated calcium signal transducer 2
API referenceFor AI assistants

Gene · 4070

Papers3,230

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

361 to 380 of 3,230

Download this page as JSON
TitleJournalYearPMIDFound bySource
Antibody-drug conjugates: A new twist to overcome EGFR-TKIs resistance in non-small cell lung cancer.Pharmacol Res202641391577PubTator, text miningPubMed
Molecular pathology of bladder cancer.Histopathology202641384708PubTator, text miningPubMed
Antibody-Drug Conjugates in urothelial, prostate, and renal cell cancers: A review of current and emerging therapies.Crit Rev Oncol Hematol202641344557PubTator, text miningPubMed
Targeting TROP2 Across Solid Tumors: The Clinical Profile and Role of Datopotamab Deruxtecan.Ann Pharmacother202641321283PubTator, text miningPubMed
The therapeutic antibody sacituzumab induces trophoblast cell-surface antigen-2 conformational rearrangement.Structure202641314216PubTator, text miningPubMed
Sacituzumab tirumotecan in participants with advanced or metastatic urothelial carcinoma and disease progression after chemotherapy and immune checkpoint inhibitors.Ann Oncol202641276258PubTator, text miningPubMed
Exploring novel therapeutic targets in vulvar squamous cell carcinoma.Gynecol Oncol202641275789PubTator, text miningPubMed
Research on precision treatment of pancreatic cancer targeted by antibody-drug conjugates.Biosci Trends202641260659PubTator, text miningPubMed
New developments in the treatment of cervical cancer in 2026.Curr Opin Obstet Gynecol202641247725PubTator, text miningPubMed
Antibody-drug conjugates in lung cancer: current landscape and future perspectives.Curr Opin Oncol202641222552PubTator, text miningPubMed
Review of design strategies for active targeted drug delivery systems for pancreatic cancer.Eur J Pharm Biopharm202641218726PubTator, text miningPubMed
Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding.Cancer Discov202641212147PubTator, text miningPubMed
Multifaceted transcriptional reprogramming supports oxaliplatin chemoresistance in colorectal cancer cells.Anticancer Drugs202641175392PubTator, text miningPubMed
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 Study.J Thorac Oncol202641173143PubTator, text miningPubMed
A TNBC-targeting nano-radiosensitizer reverses radioresistance by synergizing GSH scavenging with dual inhibition of Trop2 and lncRNA MNX1-AS1.Biomaterials202641130126PubTator, text miningPubMed
TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I non-small cell lung cancer.J Thorac Cardiovasc Surg202640976544PubTator, text miningPubMed
68Ga-MY6349 PET/CT-guided TROP2-targeted therapy in mCRPC.Eur J Nucl Med Mol Imaging202640864221PubTator, text miningPubMed
Preparation of baicalin nano prodrug and its effect on inhibiting metastasis of triple-negative breast cancer.Biomater Adv202640850054PubTator, text miningPubMed
The Future of Novel Antibody-drug Conjugates in Localized Urothelial Cancer.Eur Urol Focus202640731246PubTator, text miningPubMed
[Penile carcinoma: the importance of histological classification and new treatment strategies].Aktuelle Urol202640719092PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4070/papers?page=19

API referenceFor AI assistants